Scientific Committee

Mustafa al'Absi, Ph.D., L.P., FABMR, Professor, Department of Family Medicine and Biobehavioral Health.; Max & Mary LaDue Pickworth Chair, Director, Behavioral Medicine Laboratories, Duluth & Minneapolis), Director, Duluth Global Health Research Institute (DGHRI), University of Minnesota Medical School
Kathleen T. Brady M.D., Ph.D., Distinguished University Professor, Vice President for Research, Medical University of South Carolina, Professor of Psychiatry, USA. Principal Investigator, MUSC’s Clinical and Translational Science Award (CTSA), Principal Investigator of the Southern Consortium Node of the NIDA-funded Clinical Trials Network, Director of MUSC’s Women’s Research Center, and President, International Society for Addiction Medicine (ISAM).

Steven W. Gust, Ph.D., Director,  NIDA’s International Program. Leads NIDA leader of global research, research training, and education efforts. Liaison within NIH and other U.S. agencies, foreign governments, and international, regional, and nongovernmental organizations.

Ridha Joober MD, PhD., Professor of Psychiatry, McGill University, Clinician Scientist,  Douglas Mental Health University Institute

 

Atalay Alem, MD, PhD, Professor, Director WHO collaborative Center, Department of Psychiatry, Addis Ababa University, Consultant Psychiatrist, Tikur Ambessa Hospital, Addis Ababa, Ethiopia

Fatima El Omari, MD, Professor, Psychiatry Hospital Rabat, and Mohammed V University of Rabat

Peter W. Kalivas, Ph.D., Distinguished University Professor and Co-Chair, Department of Neuroscience, Medical University of South Carolina, USA

Noeline Nakasujja, MBChB, MMed. Psych, PhD, Associate Professor of Psychiatry, Chair, Department of Psychiatry, School of Medicine, Makerere University College of Health Sciences, Uganda

 

Serge Ahmed, Ph.D., Chef d'équipe, Directeur de recherche CNRS, Prise de décision pathologique dans l'addiction
IMN

Michael Odenwald, Ph.D.,University of Konstanz, Germany

Jane Marie Ong'olo, Ph.D., Kenya, Head of Division, Social Welfare, Vulnerable Groups and Drug Control at African Union Commission

Richard Rawson, Ph.D., Professor of Psychiatry, University of Vermont, and University of California Los Angeles, USA

Soraya Seedat, MBChB, MMed (Psych), PhD, Distinguished Professor of Psychiatry and Executive Head of the Department of Psychiatry at Stellenbosch University; The South African Research Chair in Posttraumatic Stress Disorder from the Department of Science and Technology and National Research Foundation. Co-director of the Medical Research Council Unit on Anxiety and Stress Disorders.

Markos Tesfaye, MD, Ph.D,  Professor of Psychiatry, Jimma University, Ethiopia. Postdoctoral Fellow at National Institutes of Health (NIH): Intramural Research Program (IRP)

Jallal Toufiq,MD, Ph.D., Professor of Psychiatry, Rabat Faculty of Medicine, Head of the National Centre for Drug Abuse Prevention and Research; Director of the Moroccan National Observatory on Drugs and Addictions; Director of the Ar-raziUniversity Psychiatric Hospital and Professor of Psychiatry at the Rabat Faculty of Medicine, Morocco

Maher A. Karam-Hage, M.D., Professor, Department of Behavioral Science, Division of Division of Cancer Prevention and Population Sciences; Medical Director, Tobacco Treatment Program; Professor (Joint Appointment), Department of Psychiatry, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Abdullah Alsharqi, MD, Vice President of Saudi Psychiatric association, Consultant of psychiatry and addiction medicine, PsychCare Center, Riyadh, Saudi Arabia

David Ndetei, MD, Ph.D., Professor of Psychiatry at the University of Nairobi, Founding Director of Africa Mental Health Foundation (AMHF), Kenya

2020 AMECA Congress